Stock ILMN ILLUMINA, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Illumina, Inc.

Equities

ILMN

US4523271090

Delayed Nasdaq
Other stock markets
 03:45:49 2024-04-19 pm EDT 		5-day change 1st Jan Change
117.2 USD +0.45% Intraday chart for Illumina, Inc. -7.80% -15.86%
Apr. 16 ANALYST RECOMMENDATIONS : AMD, Colgate, Fair Isaac, Tyson Foods, AstraZeneca Our Logo
Apr. 16 Baptista Research Downgrades Illumina to Hold From Buy, Adjusts PT to $149.60 From $145 MT

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
ANALYST RECOMMENDATIONS : AMD, Colgate, Fair Isaac, Tyson Foods, AstraZeneca
Our Logo
Baptista Research Downgrades Illumina to Hold From Buy, Adjusts PT to $149.60 From $145
MT
Illumina's planned divestment of GRAIL approved by the European Commission
AQ
Illumina's planned divestment of GRAIL approved by the European Commission
PR
Leerink Partners Adjusts Illumina's Price Target to $155 From $170
MT
Illumina Secures European Commission's Approval for Grail Divestment
MT
European Commission Clears Illumina's Proposed Sale of Cancer Test Maker Grail
MT
EU approves Illumina's plan to divest cancer test maker Grail
RE
Illumina CFO Goswami to depart, former Summit Therapeutics exec Dhingra to succeed
RE
Illumina Names Ankur Dhingra as Chief Financial Officer
MT
Illumina CFO Goswami to depart, Summit Therapeutics' Dhingra named successor
RE
Illumina appoints Ankur Dhingra Chief Financial Officer, Jakob Wedel Chief Strategy and Corporate Development Officer
PR
Illumina, Inc. Announces Chief Financial Officer Changes
CI
Illumina, Inc. Announces Executive Changes
CI
RBC Cuts Price Target on Illumina to $253 From $258, Keeps Outperform Rating
MT
Illumina to Announce First Quarter 2024 Financial Results on Thursday, May 2, 2024
PR
GRAIL Presents New Data on Galleri and Its Methylation Platform at the Annual American Association for Cancer Research Meeting
AQ
US Equity Markets Close Higher Thursday, Extending Gains From Wednesday
MT
Illumina Shares Up After EU Court Adviser Says Antitrust Regulators Overstepped in Halting Grail Merger
MT
Boost for Illumina as court adviser rejects EU merger powers
RE
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ILMN Stock
  4. News Illumina, Inc.